Gastric Cancer

, Volume 12, Issue 1, pp 56–65 | Cite as

The first European Union Network of Excellence for Gastric Cancer conference, Rome, Italy, April 2008

  • William Allum
  • Alfredo Garofalo
  • Maurizio Degiuli
  • Christoph Schuhmacher
Meeting Report


Gastric Cancer Endoscopic Submucosal Dissection Early Gastric Cancer Endoscopic Mucosal Resection Minimally Invasive Esophagectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, et al. Left thoracoabdominal approach versus abdominaltranshiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 2006 Aug;7:644–651.PubMedCrossRefGoogle Scholar
  2. 2.
    Hermanek P, Wittekind C. The pathologist and the residual tumor (R) classification. Pathol Res Pract 1994;190:115–123.PubMedGoogle Scholar
  3. 3.
    Kampschöer GH, Maruyama K, van de Velde CJ, Sasako M, Kinoshita T, Okabayashi K. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 1989;76:905–908.PubMedCrossRefGoogle Scholar
  4. 4.
    Goh P, Tekant Y, Isaac J, Kum CK, Ngoi SS. The technique of laparoscopic Billroth II gastrectomy. 1: Surg Laparosc Endosc 1992;2:258–260.PubMedGoogle Scholar
  5. 5.
    Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85:1457–1459.PubMedCrossRefGoogle Scholar
  6. 6.
    Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson MS, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20.PubMedCrossRefGoogle Scholar
  7. 7.
    Boige V, Pignon J, Saint-Aubert B, Lasser P, Conroy T, Bouché O, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol 2007;25(18S):4510.Google Scholar
  8. 8.
    Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725–730.PubMedCrossRefGoogle Scholar
  9. 9.
    Stahl M, Walz MK, Stuschke M, Lehmann N, Seegenschmiedt MH, Riera Knorrenschild J, et al. Preoperative chemotherapy (CTX) versus preoperative chemoradiotherapy (CRTX) in locally advanced esophagogastric adenocarcinomas: First results of a randomized phase III trial. J Clin Oncol 2007;25(18S):4511.Google Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2009

Authors and Affiliations

  • William Allum
    • 1
  • Alfredo Garofalo
    • 1
  • Maurizio Degiuli
    • 1
  • Christoph Schuhmacher
    • 1
  1. 1.Department of SurgeryRoyal Marsden NHS Foundation TrustLondonUK

Personalised recommendations